Is the Transurban share price too expensive?

Transurban boasts some attractive investment characteristics including sky high profit margins. But are the shares too expensive?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Transurban Group (ASX: TCL) shares are up close to 30% over the past year alone as the yield hunt intensifies on the back of falling Australian cash rates. Based on today's $14.64 share price and guidance for 62 cents per share in distributions over FY 2020 the stock offers an estimated 4.23% yield. This is low compared to historical standards, but still attractive compared to the pathetic returns available on cash savings rates. 

Today it announced it has refinanced $1,650 million worth of syndicated bank debt into two separate tranches of $825 million with terms to maturity of 3 to 5 years respectively.

Transurban reported the refinancing completed on "favourable" terms, although no specific financials or benefits were reported.

The debt is to help finance the group's major Melbourne West Gate Tunnel project, among other expensive construction projects it's undertaking in Victoria, Sydney and the US. 

a woman

Should you buy?

Given debt is so cheap today it makes sense to invest for Transurban, although the key risks for investors remain too much leverage or a change in the interest rate cycle. The latter could prove a double whammy for Transurban as the interest on its gross debt rises, while its free cash flows used to pay dividends become less attractive to investors. These scenarios would likely equal a lower valuation and share price. 

Overall though it's a quality business model with the sky high group EBITDA margins of 75.4% usually at levels reserved for sexy software businesses.

The margins are so strong because once a toll road is built it requires little ongoing maintenance or staff support, as it's just a question of sitting back and collecting the toll revenue. 

In fact building toll roads by issuing debt is one of the oldest business models in the world first employed by the Romans who built straight toll roads and tolled bridges to get travellers around.

Some Roman roads are still toll roads today. This is a business model likely to last the test of time then as is reflected by the impressive long-terms for Transurban returns. 

Overall, Transurban has a solid business model on paper, but it's not immune from risks around leverage or equity investors demanding a greater yield in compensation for the balance sheet and operational risks around the business.

I'd probably sit on the fence with a 'hold' rating today. 

Another monopoly-style business unsurprisingly popular with investors is Sydney Airport Ltd (ASX: SYD). It could also be worth some more research. 

Motley Fool contributor Tom Richardson owns shares of Dicker Data Limited.

You can find Tom on Twitter @tommyr345

The Motley Fool Australia owns shares of and has recommended Dicker Data Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

The silhouettes of ten people holding hands with their arms raised against the sky, as the sun rises or sets in the background.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy hump day session for the ASX.

Read more »

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

Scientists working in the laboratory and examining results.
Opinions

3 reasons to buy CSL shares today

The ASX biotech company has great growth potential this year.

Read more »

a man weraing a suit sits nervously at his laptop computer biting into his clenched hand with nerves, and perhaps fear.
Share Fallers

Why Brightstar, EQ Resources, Novonix, and Pro Medicus shares are falling today

These shares are under pressure on hump day. But why?

Read more »

A happy family of four on holidays stand on a jetty and cheer.
Broker Notes

Down 40% in 2026, should you buy the big dip in Life360 shares?

A leading analyst offers his outlook for Life360 shares.

Read more »

Buy and sell on yellow paper with pins on them and several share price lines.
Broker Notes

Sell alert! Why this expert is calling time on Nuix and Brainchip shares

A leading analyst forecasts more pain to come for Brainchip and Nuix shares. But why?

Read more »

Ecstatic woman looking at her phone outside with her fist pumped.
Share Gainers

Why EOS, Humm, New Hope, and Sims shares are storming higher today

These shares are having a good session on hump day. But why?

Read more »

a man lies on his back on grass with his eyes shut and a contented look on his face as though he is dreaming
Broker Notes

With global populations ageing, are ResMed shares a good buy today?

A leading expert delivers his verdict on the outlook for ResMed shares.

Read more »